The State of Biomedical Science in the US: How Did We Get Here and What Can We Do?
The 177th Cutter Lecture on Preventive Medicine
Abstract: The decades following the Vandervar Bush report on governmental investment in scientific research were times of extraordinary growth and innumerable accomplishments for the US biomedical research enterprise. NIH funding grew from 45 million dollars in 1945 to over 41 billion dollars by 2020. Health outcomes improved dramatically, at least in part because of the science generated by that investment. Heading into 2020, the future of US biomedical research appeared remarkably bright. Adding in the extraordinary response of our scientific and clinical systems to the COVID-19 pandemic, few would have predicted the current challenges facing biomedical research in the US. Understanding how we got here is a first step towards restoring the trajectory of biomedical research in the US.
This hybrid event offers livestream and in-person viewing options (with limited in-person seating). Seats in the main auditorium are first come, first served. There will also be a recording of the event for those who cannot attend.
Stay for the reception 5:00-6:00PM in Sebastian’s Cafe.
Open to the public.
Speakers will share their own perspectives; they do not speak for Harvard.
Speaker Information
Organizers
ⓘ Harvard Chan School hosts a diverse array of speakers, invited to share both scholarly research and personal perspectives. They do not speak for the School, and hosting them does not imply endorsement of their views, organizations, or employers.